Perspectives

The Safety of Medicines in the 21st Century – some thoughts

Sadly, although there are plans to continue the Erice meetings to consider other globally important aspects of pharmacology, therapeutics and drug safety, "A New Erice Report Considering the Safety of Medicines in the 21st Century"1was published just after the death...

[more]
Archive

Focus on

The safety profile of direct oral anticoagulants
Direct oral anticoagulants (DOACs), also known as New Oral Anticoagulants (NAOs), have for the first time provided a therapeutic alternative to vitamin K antagonists (VKAs), of which warfarin is the prototype, indicating neither inferiority nor superiority in the prevention of stroke in case of non...
[more]
Archive

Columns

Drugs & Pregnancy
Antiepileptic drugs in pregnancy: what are the risks for foetal development?
In an article that appeared in Focus Pharmacovigilance in 2014 the main adverse effects of antiepileptic drugs were discussed.1 In this article it was emphasised that the use of these drugs during pregnancy may lead to an increased risk of foetal malformations and how the extent of this risk varies...
[more]
Archive

From regulatory agencies

12 November 2018 CADTH
New at CADTH - November 2018
15 October 2018 EMA
Comunicazione EMA sulla revisione dei sartani (15/10/2018)
11 October 2018 AIFA
Nota Informativa Importante sui medicinali iniettabili a base di idarubicina cloridrato (25/10/2018)
10 October 2018 AIFA
Nota Informativa Importante su Idroclorotiazide (17/10/2018)
10 October 2018 CADTH
New at CADTH - October 2018
08 October 2018 AIFA
Nota Informativa Importante su Sildenafil (11/10/2018)
05 October 2018 EMA
Comunicazione EMA su Antibiotici Fluorochinolonici e chinolonici (05/10/2018)
28 September 2018 EMA
Comunicazione EMA su valsartan (28/09/2018)
28 September 2018 AIFA
Nota Informativa Importante su Rivaroxaban (Xarelto) (03/10/2018)
28 September 2018 AIFA
Nota Informativa Importante su LYNPARZA (Olaparib) (28/09/2018)
Link